Blanchette CM - Search Results

1

Incidence and Cost of Ankle Sprains in United States Emergency Departments.

Shah S, Thomas AC, Noone JM, Blanchette CM, Wikstrom EA. Shah S, et al. Among authors: blanchette cm. Sports Health. 2016 Nov/Dec;8(6):547-552. doi: 10.1177/1941738116659639. Epub 2016 Jul 30. Sports Health. 2016. PMID: 27474161 Free PMC article.

2

Cachexia & debility diagnoses in hospitalized children and adolescents with complex chronic conditions: evidence from the Kids' Inpatient Database.

Van Doren BA, Roy D, Noone JM, Blanchette CM, Arthur ST. Van Doren BA, et al. Among authors: blanchette cm. Drugs Context. 2015 Feb 27;4:212277. doi: 10.7573/dic.212277. eCollection 2015. Drugs Context. 2015. PMID: 25767549 Free PMC article.

3

Cachexia among US cancer patients.

Arthur ST, Van Doren BA, Roy D, Noone JM, Zacherle E, Blanchette CM. Arthur ST, et al. Among authors: blanchette cm. J Med Econ. 2016 Sep;19(9):874-80. doi: 10.1080/13696998.2016.1181640. Epub 2016 May 11. J Med Econ. 2016. PMID: 27100202 Free article.

4

The value of self-medication: summary of existing evidence.

Noone J, Blanchette CM. Noone J, et al. Among authors: blanchette cm. J Med Econ. 2018 Feb;21(2):201-211. doi: 10.1080/13696998.2017.1390473. Epub 2017 Nov 3. J Med Econ. 2018. PMID: 28994329 Free article. Review.

5

One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA.

Arthur ST, Noone JM, Van Doren BA, Roy D, Blanchette CM. Arthur ST, et al. Among authors: blanchette cm. Drugs Context. 2014 Jul 31;3:212265. doi: 10.7573/dic.212265. eCollection 2014. Drugs Context. 2014. PMID: 25126097 Free PMC article.

6

The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.

Bril V, Blanchette CM, Noone JM, Runken MC, Gelinas D, Russell JW. Bril V, et al. Among authors: blanchette cm. J Diabetes Complications. 2016 Sep-Oct;30(7):1401-7. doi: 10.1016/j.jdiacomp.2016.05.007. Epub 2016 May 10. J Diabetes Complications. 2016. PMID: 27389526 Free PMC article. Review.

7

Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States.

Runken MC, Noone JM, Blanchette CM, Zacherle E, Howden R. Runken MC, et al. Among authors: blanchette cm. Am Health Drug Benefits. 2019 Oct;12(6):294-304. Am Health Drug Benefits. 2019. PMID: 31908713 Free PMC article.

8

Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.S.

Blanchette CM, Noone JM, Stone G, Zacherle E, Patel RP, Howden R, Mapel D. Blanchette CM, et al. Med Sci (Basel). 2017 Sep 23;5(4):20. doi: 10.3390/medsci5040020. Med Sci (Basel). 2017. PMID: 29099036 Free PMC article.

9

Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.

Shah S, Blanchette CM, Coyle JC, Kowalkowski M, Arthur ST, Howden R. Shah S, et al. Among authors: blanchette cm. J Med Econ. 2018 Sep;21(9):861-868. doi: 10.1080/13696998.2018.1484370. Epub 2018 Jul 2. J Med Econ. 2018. PMID: 29857784 Free article.

10

Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function.

Blanchette CM, Nunes AP, Lin ND, Mortimer KM, Noone J, Tangirala K, Johnston S, Gutierrez B. Blanchette CM, et al. Drugs Context. 2015 Feb 10;4:212272. doi: 10.7573/dic.212272. eCollection 2015. Drugs Context. 2015. PMID: 25709706 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page